Genzyme Corporation
Records under this name other than the patents Genzyme Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 307 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,129,506 | Modulation of the Interaction of MUC1 with MUC1 Ligands now held by Dana-Farber Cancer Institute, Inc. In force · High confidence | In force | High confidence | |
| US 7,723,525 | Chemokine-Binding Heterocyclic Compound Salts, and Methods of Use Thereof now held by Anormed Corporation In force · High confidence | In force | High confidence | |
| US 7,723,486 | Antibodies to Tgf-Beta now held by Optein, Inc. In force · High confidence | In force | High confidence | |
| US 8,067,427 | Pharmaceutical Compositions Comprising ZD6474 now held by Esteve Pharmaceuticals, S.A. In force · High confidence | In force | High confidence | |
| US 10,213,494 | Treatment of Synucleinopathies now held by The Brigham and Women's Hospital, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 9,777,314 | Analysis of Heterogeneous Nucleic Acid Samples now held by Esoterix Genetic Laboratories, LLC In force · High confidence | In force | High confidence | |
| US 8,709,711 | Methods of Measuring Cell Viability in Tissue Engineered Products now held by Vericel Corporation In force · Medium confidence | In force | Medium confidence | |
| US 9,498,528 | Treatment of multiple sclerosis (MS) now held by Alcafleu Management GmbH & Co. KG. In force · High confidence | In force | High confidence | |
| US 8,454,954 | Treatment of Synucleinopathies now held by The Brigham and Women's Hospital, Inc. In force · High confidence | In force | High confidence | |
| US 8,703,811 | Small Molecule Inhibitors of Plasmodium Falciparum Dihydroorotate Dehydrogenase now held by President and Fellows of Harvard College In force · High confidence | In force | High confidence |